Navigation Links
Polar USA Named a Best Company to Work for in New York for Second Straight Year
Date:6/3/2011

LAKE SUCCESS, N.Y., June 3, 2011 /PRNewswire/ -- Polar (www.polarusa.com), the leader in heart rate and fitness assessment technology, today announced it has been named a "Best Company to Work for in New York for 2011" by the New York State Society for Human Resource Management, Inc., the Business Council of New York and Best Companies Group.  Polar ranked 22 in the under 250 employees group. The award honors companies who excel in workplace policies, practices, philosophies, systems and demographics and perform well in an employee survey that measures their experiences.  

"We feel honored to be recognized for the second year in a row for this prestigious award," said Jeff Padovan, president of Polar USA.  "Every year, we continue to find ways to keep our team engaged and invest in employee development.  This award shows that those efforts are seen and appreciated."  

"This competition was designed to identify, recognize, and honor the best places of employment in the Empire State, to the benefit of our economy, labor force, and businesses," said Lorri Zelman, chair of the Best Companies to Work for in New York Program.  "Polar USA is one of those companies – I congratulate them on their accomplishment."

Polar has developed a number of creative recognition programs and employee engagement initiatives, including the "Leader of the Pack" award – an initiative that recognizes employees who embody the core values of Polar – and "Bring Your Own Food Day" – a program that promotes the sharing of culinary talents.  Some activities make use of Polar technology including the company's internal version of "March Madness" and "Office Olympics," as well as participation in the Workman Workplace Challenge, in which the Polar men's team placed third overall.

About PolarHeadquartered in Lake Success, NY, Polar USA is a wholly-owned subsidiary of Finland-based Polar Electro OY, which invented the first wireless heart rate monitor (HRM) in 1977.  Polar now operates internationally in more than 80 countries. Polar heart rate and fitness assessment technology delivers unparalleled insight into the human body from valuable training guidance and feedback, to enabling individuals to improve their fitness level and sports performance. Polar technology is key to the success of leading fitness facilities, athletic teams, corporate wellness facilities, health insurance providers and thousands of physical education programs around the world. Today, Polar training computers are the number one choice among consumers worldwide. For more information, visit www.polarusa.com.Maria Martinez

Kathleen Reynolds CooperKatz for Polar USA

CooperKatz for Polar USA917-595-3059

917-595-3031mmartinez@cooperkatz.com

kreynolds@cooperkatz.com
'/>"/>

SOURCE Polar USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
2. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
3. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
4. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
5. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
6. NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
7. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
8. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
9. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
10. U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
11. Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):